Immunome Stock Jumps On Discovery Pact With AbbVie
AbbVie Inc (NYSE:ABBV) and Immunome Inc (NASDAQ:IMNM) announced a worldwide collaboration and option agreement to discover up to 10 novel antibody-target pairs arising…
Why Leslie’s Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.
Immunome Announces Publication In Clinical & Translational Immunology Highlighting B Cell Repertoires In Patients with Breast Cancer
The study demonstrates the importance of tumor and lymph node-derived B cells for the discovery of antibodies directed at potentially novel targets
The study results provide a framework for understanding the evolution
Recap: Immunome Q2 Earnings
Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.
Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants
Immunome Inc (NASDAQ:IMNM) has announced that its cocktail (IMM-BCP-01) retained activity against the BA.4/5 and BA.2.12.1 subvariants in lab testing. IMM-BCP-01…
Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
Short Volatility Alert: Immunome, Inc.
On Modnay, shares of Immunome, Inc. (NASDAQ: IMNM) experienced volatile short activity. After the activity, the stock price went up +0.30% to $3.31.
The overall sentiment for IMNM has been Bearish.
Immunome Shares Rise After Publishing Positive COVID-19 Antibody Cocktail Data
Immunome Inc (NASDAQ:IMNM) shares are trading higher after it published data demonstrating that its COVID-19 antibody cocktail, IMM-BCP-01, potently cleared…
Why Immunome Shares Are Rising
Immunome Inc (NASDAQ: IMNM) shares are trading higher by 19.44% at $3.39 after the company published data demonstrating its COVID-19 antibody cocktail IMM-BCP-01 cleared the omicron variant of SARS-CoV-2 when tested in vivo in hamsters.
38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.